GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Belluscura PLC (FRA:9VQ) » Definitions » Other Operating Expense

Belluscura (FRA:9VQ) Other Operating Expense : €4.21 Mil (TTM As of Jun. 2023)


View and export this data going back to 2021. Start your Free Trial

What is Belluscura Other Operating Expense?

Belluscura's Other Operating Expense for the six months ended in Jun. 2023 was €2.26 Mil. Its Other Operating Expense for the trailing twelve months (TTM) ended in Jun. 2023 was €4.21 Mil.

Belluscura's quarterly Other Operating Expense declined from Jun. 2022 (€4.26 Mil) to Dec. 2022 (€1.95 Mil) but then increased from Dec. 2022 (€1.95 Mil) to Jun. 2023 (€2.26 Mil).

Belluscura's annual Other Operating Expense increased from Dec. 2020 (€0.92 Mil) to Dec. 2021 (€2.58 Mil) and increased from Dec. 2021 (€2.58 Mil) to Dec. 2022 (€6.21 Mil).


Belluscura Other Operating Expense Historical Data

The historical data trend for Belluscura's Other Operating Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Belluscura Other Operating Expense Chart

Belluscura Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22
Other Operating Expense
0.75 0.82 0.92 2.58 6.21

Belluscura Semi-Annual Data
Dec18 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23
Other Operating Expense Get a 7-Day Free Trial Premium Member Only 1.22 1.29 4.26 1.95 2.26

Belluscura Other Operating Expense Calculation

GuruFocus uses a standardized financial statement format for all companies. For non-financial companies, GuruFocus lists Selling, General, & Admin. Expense, , Research & Development, and Other Operating Expense under the "Total Operating Expense" section.

Other Operating Expense sometimes includes:
Restructuring, and merger
Acquisition related and other
Litigation settlement charge
Other (too numerous to list)

Some companies can and do choose to report each of these items separately. Yet, there are a variety of Other Operating Expense which are simply too numerous to list.

Other Operating Expense for the trailing twelve months (TTM) ended in Jun. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was €4.21 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Belluscura Other Operating Expense Related Terms

Thank you for viewing the detailed overview of Belluscura's Other Operating Expense provided by GuruFocus.com. Please click on the following links to see related term pages.


Belluscura (FRA:9VQ) Business Description

Traded in Other Exchanges
Address
15 Fetter Lane, Holborn, London, GBR, EC4A 1BW
Belluscura PLC is a medical device company. Its first product, the X-PLOR, is a lightweight FDA-cleared portable oxygen concentrator designed to replace larger, metal oxygen tanks and heavier portable oxygen concentrator devices. The X-PLO2R weighs less than 1.5kg (3.25 lbs) and it is the first modular portable oxygen concentrator it will generate more oxygen by weight than any other FDA-cleared POC in its class. It either owns or exclusively licenses a total of 26 patents and applications relating to oxygen enrichment devices and treatments.

Belluscura (FRA:9VQ) Headlines

No Headlines